These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 11940054

  • 1. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y, Hamazu M, Kajita Y, Nagata A.
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [Abstract] [Full Text] [Related]

  • 2. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 3. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
    Noh J, Hamada N, Saito H, Oyanagi H, Ishikawa N, Momotani N, Ito K, Morii H.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
    [Abstract] [Full Text] [Related]

  • 4. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY, Shong YK, Lee HK, Koh CS, Min HK.
    Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
    [Abstract] [Full Text] [Related]

  • 5. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies.
    Akamizu T, Mori T, Kasagi K, Kosugi S, Miyamoto M, Nishino K, Sugawa H, Yokota T, Nakamura H, Konishi J.
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477
    [Abstract] [Full Text] [Related]

  • 6. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
    Saiki Y, Ishihara T, Ikekubo K, Mori T.
    Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557
    [Abstract] [Full Text] [Related]

  • 7. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D, Massart C.
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [Abstract] [Full Text] [Related]

  • 8. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
    Wallaschofski H, Kaczmarek M, Miehle K, Hentschel B, Paschke R.
    Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
    [Abstract] [Full Text] [Related]

  • 9. Interference with thyrotropin receptor antibody determination by a spuriously occurring anti-bovine TSH antibody.
    Iitaka M, Tanikawa T, Sakatsume Y, Yanagisawa M, Hara Y, Ishii J.
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):197-203. PubMed ID: 2874680
    [Abstract] [Full Text] [Related]

  • 10. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M, Nakao Y, Baba Y, Kobayashi N, Matsukura S, Kuma K, Fujita T.
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [Abstract] [Full Text] [Related]

  • 11. Anti-TSH antibodies in Graves' disease and their failure to interact with TSH receptor antibodies.
    Ochi Y, Nagamune T, Nakajima Y, Ishida M, Kajita Y, Hachiya T, Ogura H.
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):773-7. PubMed ID: 2567103
    [Abstract] [Full Text] [Related]

  • 12. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y, Kajita Y, Hamazu M, Nagata A.
    Horm Res; 2003 Jun; 59(5):222-8. PubMed ID: 12714785
    [Abstract] [Full Text] [Related]

  • 13. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [Abstract] [Full Text] [Related]

  • 14. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W, Man N, Li YS, Shan ZY, Teng WP.
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [Abstract] [Full Text] [Related]

  • 15. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [Abstract] [Full Text] [Related]

  • 16. Binding of bovine and porcine pituitary glycoprotein hormone alpha-subunit to TSH antibody in serum of patients with Graves' disease.
    Kajita Y, Nakajima Y, Ishida M, Fujita Y, Nagamune T, Hachiya T, Nakagawa M, Inui T, Ochi Y.
    Autoimmunity; 1990 Oct; 6(1-2):71-8. PubMed ID: 1717006
    [Abstract] [Full Text] [Related]

  • 17. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ, Kim MR, Faiman C, Kohn LD, Tahara K, Gupta MK.
    Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
    [Abstract] [Full Text] [Related]

  • 18. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
    Davies TF, Platzer M.
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
    [Abstract] [Full Text] [Related]

  • 19. Abnormal thyrotropin-binding immunoglobulins in two patients with Graves' disease.
    Akamizu T, Ishii H, Mori T, Ishihara T, Ikekubo K, Imura H.
    J Clin Endocrinol Metab; 1984 Aug; 59(2):240-5. PubMed ID: 6145722
    [Abstract] [Full Text] [Related]

  • 20. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease.
    Shinozawa T, Villadolid MC, Ingbar SH.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.